The burden of meningococcal meningitis in the African Meningitis Belt, from 2009 to 2014: a trend analysis

被引:3
作者
Jaca, Anelisa [1 ]
Wiyeh, Alison Beriliy [1 ]
Sambala, Evanson Zondani [1 ]
Wiysonge, Charles Shey [1 ,2 ,3 ]
机构
[1] South African Med Res Council, Cochrane South Africa, Francie Van Zijl Dr, ZA-7501 Parow Valley, South Africa
[2] Stellenbosch Univ, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Dept Global Hlth,Div Epidemiol & Biostat, Cape Town, South Africa
[3] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa
来源
PAN AFRICAN MEDICAL JOURNAL | 2021年 / 39卷
基金
英国医学研究理事会;
关键词
Emerging strains; MenAfriVac; meningitis; meningitis belt; serogroup A; EPIDEMIOLOGY;
D O I
10.11604/pamj.2021.39.57.17629
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Neisseria meningitides is the leading cause of meningitis in the African Meningitis Belt. The objective of this study was to conduct a trend analysis of the burden of meningococcal meningitis in the African Meningitis Belt countries from 2009 to 2014. Methods: secondary data on incidence and death cases were collected from the World Health Organization (WHO) and analyzed to determine the trends of meningitis in the African Meningitis Belt countries using Microsoft excel and Stata 14. Results: these data show unstable meningococcal meningitis outbreaks in the Meningitis Belt before and after the introduction of meningococcal A vaccine (MenAfriVac). The vaccine was introduced at different times in the different countries. E.g. it was introduced in 2010 across Burkina Faso, Mali and Niger while it was introduced from 2011 to 2016 in other countries through mass campaigns. Ever since the vaccine was introduced, there has been a decrease in the number of cases in the countries hence a reduction in the burden of the disease. Conclusion: after the introduction of the MenAfriVac, there has been a decline in the meningitis cases in Benin, Burkina Faso, Chad, Ghana, Niger and Nigeria while Sudan shows a decrease only in 2014.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018
    Bwaka, Ado
    Bita, Andre
    Lingani, Clement
    Fernandez, Katya
    Durupt, Antoine
    Mwenda, Jason M.
    Mihigo, Richard
    Djingarey, Mamoudou H.
    Ronveaux, Olivier
    Preziosi, Marie-Pierre
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 : S140 - S147
  • [12] Invasive Meningococcal Disease in Africa's Meningitis Belt: More Than Just Meningitis?
    Reese, Heather E.
    Ronveaux, Olivier
    Mwenda, Jason M.
    Bita, Andre
    Cohen, Adam L.
    Novak, Ryan T.
    Fox, LeAnne M.
    Soeters, Heidi M.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 : S263 - S265
  • [13] Modelling control strategies for pneumococcal meningitis outbreaks in the African meningitis belt
    Hadley, Liza
    Soeters, Heidi M.
    V. Cooper, Laura
    Fernandez, Katya
    Latt, Anderson
    Fouda, Andre A. Bita
    Trotter, Caroline
    VACCINE, 2024, 42 (20)
  • [14] Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis
    Munguambe, Alcides Moniz
    Castro Cardoso de Almeida, Antonio Eugenio
    Nhantumbo, Aquino Albino
    Come, Charlotte Elizabeth
    Zimba, Tomaas Francisco
    Langa, Jose Paulo
    de Filippis, Ivano
    Gudo, Eduardo Samo
    PLOS ONE, 2018, 13 (08):
  • [15] Compartmental models for seasonal hyperendemic bacterial meningitis in the African meningitis belt
    Koutangni, T.
    Crepey, P.
    Woringer, M.
    Porgho, S.
    Bicaba, B. W.
    Tall, H.
    Mueller, J. E.
    EPIDEMIOLOGY AND INFECTION, 2019, 147
  • [16] The actual and potential costs of meningitis surveillance in the African meningitis belt: Results from Chad and Niger
    Irurzun-Lopez, Maite
    Erondu, Ngozi A.
    Djibo, Ali
    Griffiths, Ulla
    Stuart, James M.
    Fernandez, Katya
    Ronveaux, Olivier
    Le Gargasson, Jean-Bernard
    Gessner, Bradford D.
    Colombini, Anais
    VACCINE, 2016, 34 (08) : 1133 - 1138
  • [17] Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana
    Cooper, Laura V.
    Stuart, James M.
    Okot, Charles
    Asiedu-Bekoe, Franklin
    Afreh, Osei Kuffour
    Fernandez, Katya
    Ronveaux, Olivier
    Trotter, Caroline L.
    VACCINE, 2019, 37 (37) : 5657 - 5663
  • [18] Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt
    Tunheim, G.
    Naess, L. M.
    Acevedo, R.
    Fjeldheim, A. K.
    Bolstad, K.
    Garcia, L.
    Cardoso, D.
    Aase, A.
    Zayas, C.
    Gonzalez, H.
    Rosenqvist, E.
    Norheim, G.
    VACCINE, 2014, 32 (49) : 6631 - 6638
  • [19] Pattern of the meningococcal meningitis outbreak in Northern Nigeria, 2009
    Bassey, Bassey Enya
    Vaz, Rui Gama
    Gasasira, Alex Ntale
    Braka, Fiona
    Weldegriebriel, Goitom
    Komakech, Williams
    Toritseju, Maleghemi Sylvester
    Fatiregun, Akinola Ayoola
    Okocha-Ejeko, Angela
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 43 : 62 - 67
  • [20] Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014
    Djingarey, Mamoudou H.
    Diomande, Fabien V. K.
    Barry, Rodrigue
    Kandolo, Denis
    Shirehwa, Florence
    Lingani, Clement
    Novak, Ryan T.
    Tevi-Benissan, Carol
    Perea, William
    Preziosi, Marie-Pierre
    LaForce, F. Marc
    CLINICAL INFECTIOUS DISEASES, 2015, 61 : S434 - S441